Pictet Asset Management (UK)’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $63K | Hold |
10,800
| – | – | ﹤0.01% | 1719 |
|
|
2021
Q1 | $76K | Hold |
10,800
| – | – | ﹤0.01% | 1749 |
|
|
2020
Q4 | $52K | Hold |
10,800
| – | – | ﹤0.01% | 1718 |
|
|
2020
Q3 | $63K | Buy |
+10,800
| New | +$63K | ﹤0.01% | 1522 |
|
|
2019
Q4 | – | Sell |
-188,000
| Closed | -$739K | – | 1117 |
|
|
2019
Q3 | $739K | Buy |
188,000
+6,900
| +4% | +$27.1K | ﹤0.01% | 923 |
|
|
2019
Q2 | $2.69M | Buy |
181,100
+35,300
| +24% | +$525K | 0.01% | 810 |
|
|
2019
Q1 | $3.62M | Buy |
145,800
+48,300
| +50% | +$1.2M | 0.01% | 746 |
|
|
2018
Q4 | $1.75K | Buy |
97,500
+21,600
| +28% | +$388 | ﹤0.01% | 835 |
|
|
2018
Q3 | $2.23M | Sell |
75,900
-307,134
| -80% | -$9.02M | ﹤0.01% | 861 |
|
|
2018
Q2 | $17.4M | Buy |
383,034
+49,104
| +15% | +$2.23M | 0.04% | 424 |
|
|
2018
Q1 | $17.6M | Sell |
333,930
-65,804
| -16% | -$3.47M | 0.04% | 403 |
|
|
2017
Q4 | $27.2M | Buy |
399,734
+32,705
| +9% | +$2.22M | 0.07% | 326 |
|
|
2017
Q3 | $30.2M | Buy |
367,029
+51,366
| +16% | +$4.23M | 0.09% | 290 |
|
|
2017
Q2 | $16.3M | Buy |
315,663
+128,852
| +69% | +$6.66M | 0.05% | 390 |
|
|
2017
Q1 | $11.9M | Sell |
186,811
-8,474
| -4% | -$540K | 0.04% | 448 |
|
|
2016
Q4 | $8.68M | Buy |
+195,285
| New | +$8.68M | 0.03% | 474 |
|
|
2015
Q3 | – | Sell |
-17,200
| Closed | -$1.45M | – | 900 |
|
|
2015
Q2 | $1.45M | Sell |
17,200
-4,800
| -22% | -$405K | 0.01% | 774 |
|
|
2015
Q1 | $1.77M | Sell |
22,000
-51,533
| -70% | -$4.14M | 0.01% | 761 |
|
|
2014
Q4 | $4.12M | Buy |
+73,533
| New | +$4.12M | 0.02% | 625 |
|
|
2014
Q3 | – | Sell |
-27,900
| Closed | -$1.16M | – | 895 |
|
|
2014
Q2 | $1.16M | Sell |
27,900
-3,200
| -10% | -$132K | 0.01% | 778 |
|
|
2014
Q1 | $2.15M | Sell |
31,100
-3,900
| -11% | -$270K | 0.01% | 729 |
|
|
2013
Q4 | $2.11M | Buy |
35,000
+8,100
| +30% | +$488K | 0.01% | 728 |
|
|
2013
Q3 | $1.64M | Buy |
26,900
+12,200
| +83% | +$742K | 0.01% | 750 |
|
|
2013
Q2 | $985K | Buy |
+14,700
| New | +$985K | 0.01% | 771 |
|